{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:51:41Z","timestamp":1780451501018,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.ppat.1008736","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000}}],"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006945","name":"Texas Emerging Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AU-0042-20030616"],"award-info":[{"award-number":["AU-0042-20030616"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008736","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T17:39:47Z","timestamp":1596476387000},"page":"e1008736","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2300-4739","authenticated-orcid":true,"given":"Xiaohua","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-3375","authenticated-orcid":true,"given":"Hang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-9647","authenticated-orcid":true,"given":"Daniel","family":"Wrapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-1396","authenticated-orcid":true,"given":"Leike","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabbu","family":"Jaijyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":true,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-2180","authenticated-orcid":true,"given":"Ningyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-2271","authenticated-orcid":true,"given":"Tong-Ming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-2335","authenticated-orcid":true,"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"issue":"6","key":"ppat.1008736.ref001","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000322141","article-title":"Human Cytomegalovirus (HCMV)\u2014Revised","volume":"37","author":"V Schottstedt","year":"2010","journal-title":"Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie"},{"issue":"4","key":"ppat.1008736.ref002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"MJ Cannon","year":"2010","journal-title":"Reviews in medical virology"},{"issue":"15","key":"ppat.1008736.ref003","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity","volume":"91","author":"WJ Britt","year":"2017","journal-title":"Journal of virology"},{"issue":"1","key":"ppat.1008736.ref004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \"silent\" global burden of congenital cytomegalovirus","volume":"26","author":"S Manicklal","year":"2013","journal-title":"Clinical microbiology reviews"},{"issue":"5","key":"ppat.1008736.ref005","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/bdra.23601","article-title":"Cytomegalovirus infection in pregnancy","volume":"109","author":"NL Davis","year":"2017","journal-title":"Birth defects research"},{"issue":"7","key":"ppat.1008736.ref006","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"LS Azevedo","year":"2015","journal-title":"Clinics"},{"issue":"2","key":"ppat.1008736.ref007","first-page":"113","article-title":"Cytomegalovirus infection in patients with HIV infection","volume":"66","author":"TW Cheung","year":"1999","journal-title":"The Mount Sinai journal of medicine, New York"},{"issue":"22","key":"ppat.1008736.ref008","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.vaccine.2014.03.057","article-title":"Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease","volume":"32","author":"TM Fu","year":"2014","journal-title":"Vaccine"},{"issue":"6345","key":"ppat.1008736.ref009","article-title":"Atomic structure of the human cytomegalovirus capsid with its securing tegument layer of pp150","volume":"356","author":"X Yu","year":"2017","journal-title":"Science"},{"issue":"25","key":"ppat.1008736.ref010","doi-asserted-by":"crossref","first-page":"14976","DOI":"10.1073\/pnas.2136652100","article-title":"Coding potential of laboratory and clinical strains of human cytomegalovirus","volume":"100","author":"E Murphy","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ppat.1008736.ref011","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nmicrobiol.2016.82","article-title":"Platelet-derived growth factor-alpha receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer","volume":"1","author":"A Kabanova","year":"2016","journal-title":"Nature microbiology"},{"issue":"7211","key":"ppat.1008736.ref012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature07209","article-title":"Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection","volume":"455","author":"L Soroceanu","year":"2008","journal-title":"Nature"},{"issue":"17","key":"ppat.1008736.ref013","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1128\/JVI.01325-15","article-title":"Human Cytomegalovirus gH\/gL\/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH\/gL\/UL128-131 Broadens Virus Tropism through a Distinct Mechanism","volume":"89","author":"M Zhou","year":"2015","journal-title":"Journal of virology"},{"issue":"50","key":"ppat.1008736.ref014","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"D Wang","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"14","key":"ppat.1008736.ref015","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1073\/pnas.1814850116","article-title":"OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism","volume":"116","author":"X E","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ppat.1008736.ref016","article-title":"An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor","author":"N Martinez-Martin","year":"2018","journal-title":"Cell"},{"issue":"10","key":"ppat.1008736.ref017","doi-asserted-by":"crossref","first-page":"e1005227","DOI":"10.1371\/journal.ppat.1005227","article-title":"Crystal Structure of the Human Cytomegalovirus Glycoprotein B","volume":"11","author":"HG Burke","year":"2015","journal-title":"PLoS pathogens"},{"issue":"8","key":"ppat.1008736.ref018","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.01251-08","article-title":"Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress","volume":"83","author":"MK Isaacson","year":"2009","journal-title":"Journal of virology"},{"issue":"6947","key":"ppat.1008736.ref019","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nature01818","article-title":"Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus","volume":"424","author":"X Wang","year":"2003","journal-title":"Nature"},{"issue":"3","key":"ppat.1008736.ref020","doi-asserted-by":"crossref","first-page":"e00332","DOI":"10.1128\/mBio.00332-13","article-title":"Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein","volume":"4","author":"PT Wille","year":"2013","journal-title":"mBio"},{"issue":"2","key":"ppat.1008736.ref021","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"A Macagno","year":"2010","journal-title":"Journal of virology"},{"issue":"51","key":"ppat.1008736.ref022","doi-asserted-by":"crossref","first-page":"E4997","DOI":"10.1073\/pnas.1316517110","article-title":"Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine","volume":"110","author":"DC Freed","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"43","key":"ppat.1008736.ref023","doi-asserted-by":"crossref","first-page":"73654","DOI":"10.18632\/oncotarget.18359","article-title":"Active evolution of memory B-cells specific to viral gH\/gL\/pUL128\/130\/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection","volume":"8","author":"L Xia","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"ppat.1008736.ref024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123982","article-title":"A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I)","volume":"19","author":"MM McVoy","year":"2018","journal-title":"International journal of molecular sciences"},{"issue":"8","key":"ppat.1008736.ref025","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00382-16","article-title":"In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539","volume":"60","author":"HD Patel","year":"2016","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"8","key":"ppat.1008736.ref026","doi-asserted-by":"crossref","first-page":"e1002172","DOI":"10.1371\/journal.ppat.1002172","article-title":"B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies","volume":"7","author":"S Potzsch","year":"2011","journal-title":"PLoS pathogens"},{"issue":"Pt 9","key":"ppat.1008736.ref027","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1099\/0022-1317-73-9-2375","article-title":"Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies","volume":"73","author":"H Meyer","year":"1992","journal-title":"The Journal of general virology"},{"issue":"3","key":"ppat.1008736.ref028","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/175.3.533","article-title":"The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies","volume":"175","author":"K Schoppel","year":"1997","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"ppat.1008736.ref029","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1399-3062.2010.00563.x","article-title":"Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors","volume":"13","author":"K Ishibashi","year":"2011","journal-title":"Transplant infectious disease: an official journal of the Transplantation Society"},{"issue":"12","key":"ppat.1008736.ref030","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiy102","article-title":"Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia","volume":"217","author":"I Baraniak","year":"2018","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ppat.1008736.ref031","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/infdis\/jiw487","article-title":"Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants","volume":"214","author":"KM Bialas","year":"2016","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"ppat.1008736.ref032","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01433-16","article-title":"Genome Sequences of Diverse Human Cytomegalovirus Strains with Utility in Drug Screening and Vaccine Evaluation","volume":"5","author":"K Corcoran","year":"2017","journal-title":"Genome announcements"},{"issue":"6","key":"ppat.1008736.ref033","first-page":"331","article-title":"CytoGam infusions at home","volume":"22","author":"D. Hammond","year":"1999","journal-title":"Journal of intravenous nursing: the official publication of the Intravenous Nurses Society"},{"key":"ppat.1008736.ref034","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: an open bioinformatics database and analysis resource for virology research","volume":"40","author":"BE Pickett","year":"2012","journal-title":"Nucleic acids research"},{"issue":"2","key":"ppat.1008736.ref035","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"T Compton","year":"1993","journal-title":"Virology"},{"issue":"11","key":"ppat.1008736.ref036","first-page":"2598","article-title":"Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis","volume":"40","author":"B Bodaghi","year":"1999","journal-title":"Investigative ophthalmology & visual science"},{"issue":"2","key":"ppat.1008736.ref037","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JVI.69.2.1071-1078.1995","article-title":"Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport","volume":"69","author":"S Schmolke","year":"1995","journal-title":"Journal of virology"},{"issue":"3","key":"ppat.1008736.ref038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0019-2791(77)90194-X","article-title":"Cleavage sites of human IgG1 immunoglobulin by papain","volume":"14","author":"AC Wang","year":"1977","journal-title":"Immunochemistry"},{"issue":"4","key":"ppat.1008736.ref039","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/mabs.28762","article-title":"A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization","volume":"6","author":"Y An","year":"2014","journal-title":"mAbs"},{"issue":"3","key":"ppat.1008736.ref040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"DI Bernstein","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"ppat.1008736.ref041","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"RF Pass","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"9773","key":"ppat.1008736.ref042","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"PD Griffiths","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"ppat.1008736.ref043","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"CS Nelson","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"24","key":"ppat.1008736.ref044","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"I Baraniak","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"ppat.1008736.ref045","doi-asserted-by":"crossref","first-page":"e1004377","DOI":"10.1371\/journal.ppat.1004377","article-title":"Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody","volume":"10","author":"N Spindler","year":"2014","journal-title":"PLoS pathogens"},{"key":"ppat.1008736.ref046","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1038\/ncomms9176","article-title":"Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody","volume":"6","author":"S Chandramouli","year":"2015","journal-title":"Nature communications"},{"issue":"1","key":"ppat.1008736.ref047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/CDLI.4.1.107-111.1997","article-title":"Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques","volume":"4","author":"M Ohlin","year":"1997","journal-title":"Clinical and diagnostic laboratory immunology"},{"issue":"8","key":"ppat.1008736.ref048","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1080\/21645515.2016.1164376","article-title":"Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus","volume":"12","author":"AC Finnefrock","year":"2016","journal-title":"Human vaccines & immunotherapeutics"},{"key":"ppat.1008736.ref049","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41541-017-0038-0","article-title":"Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB\/MF59 vaccination","volume":"2","author":"F Li","year":"2017","journal-title":"NPJ vaccines"},{"issue":"3","key":"ppat.1008736.ref050","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.04295-14","article-title":"A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types","volume":"59","author":"LM Kauvar","year":"2015","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"Pt 7","key":"ppat.1008736.ref051","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1099\/vir.0.19017-0","article-title":"Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion","volume":"84","author":"D Gicklhorn","year":"2003","journal-title":"The Journal of general virology"},{"issue":"4","key":"ppat.1008736.ref052","doi-asserted-by":"crossref","first-page":"e1004072","DOI":"10.1371\/journal.ppat.1004072","article-title":"Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement","volume":"10","author":"MA Edeling","year":"2014","journal-title":"PLoS pathogens"},{"issue":"18","key":"ppat.1008736.ref053","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1073\/pnas.0811427106","article-title":"Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10","volume":"106","author":"JS Klein","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"14","key":"ppat.1008736.ref054","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1128\/JVI.00545-10","article-title":"Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins","volume":"84","author":"P Wang","year":"2010","journal-title":"Journal of virology"},{"issue":"Pt 8","key":"ppat.1008736.ref055","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1099\/0022-1317-83-8-2001","article-title":"A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B","volume":"83","author":"J Lantto","year":"2002","journal-title":"The Journal of general virology"},{"issue":"8","key":"ppat.1008736.ref056","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/JVI.02710-06","article-title":"Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions","volume":"81","author":"FC Bender","year":"2007","journal-title":"Journal of virology"},{"issue":"8","key":"ppat.1008736.ref057","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1128\/JVI.02687-09","article-title":"Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH\/gL as a necessary step leading to cell fusion","volume":"84","author":"D Atanasiu","year":"2010","journal-title":"Journal of virology"},{"issue":"2","key":"ppat.1008736.ref058","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.virol.2012.09.024","article-title":"HCMV gB shares structural and functional properties with gB proteins from other herpesviruses","volume":"435","author":"S Sharma","year":"2013","journal-title":"Virology"},{"issue":"7","key":"ppat.1008736.ref059","doi-asserted-by":"crossref","first-page":"e1007914","DOI":"10.1371\/journal.ppat.1007914","article-title":"Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection","volume":"15","author":"X Ye","year":"2019","journal-title":"PLoS pathogens"},{"issue":"7","key":"ppat.1008736.ref060","article-title":"Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH\/gL\/pUL128-131","volume":"91","author":"S Ha","year":"2017","journal-title":"Pentameric Complex. J Virol"},{"issue":"6","key":"ppat.1008736.ref061","doi-asserted-by":"crossref","first-page":"e1007716","DOI":"10.1371\/journal.ppat.1007716","article-title":"Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes","volume":"15","author":"L Li","year":"2019","journal-title":"PLoS pathogens"},{"issue":"3","key":"ppat.1008736.ref062","doi-asserted-by":"crossref","first-page":"e1005454","DOI":"10.1371\/journal.ppat.1005454","article-title":"Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody","volume":"12","author":"X Ye","year":"2016","journal-title":"PLoS pathogens"},{"key":"ppat.1008736.ref063","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35383","article-title":"cisTEM, user-friendly software for single-particle image processing","volume":"7","author":"T Grant","year":"2018","journal-title":"eLife"},{"issue":"3","key":"ppat.1008736.ref064","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"A Punjani","year":"2017","journal-title":"Nature methods"},{"issue":"Pt 4","key":"ppat.1008736.ref065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"TG Battye","year":"2011","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 7","key":"ppat.1008736.ref066","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"PR Evans","year":"2013","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 4","key":"ppat.1008736.ref067","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"Journal of applied crystallography"},{"issue":"Pt 11","key":"ppat.1008736.ref068","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"PD Adams","year":"2002","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 12","key":"ppat.1008736.ref069","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"P Emsley","year":"2004","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"key":"ppat.1008736.ref070","doi-asserted-by":"crossref","first-page":"e01456","DOI":"10.7554\/eLife.01456","article-title":"Collaboration gets the most out of software","volume":"2","author":"A Morin","year":"2013","journal-title":"eLife"},{"issue":"46","key":"ppat.1008736.ref071","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1016\/j.vaccine.2011.08.086","article-title":"A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines","volume":"29","author":"A Tang","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ppat.1008736.ref072","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"RC Edgar","year":"2004","journal-title":"Nucleic acids research"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008736","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T19:09:41Z","timestamp":1597345781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008736"}},"subtitle":[],"editor":[{"given":"Robert F.","family":"Kalejta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008736","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1008736","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}